Lab to Marketplace: Tools for Biomedical and Behavioral Research (SBIR [R43/R44])

The summary for the Lab to Marketplace: Tools for Biomedical and Behavioral Research (SBIR [R43/R44]) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Lab to Marketplace: Tools for Biomedical and Behavioral Research (SBIR [R43/R44]): -Purpose. This Funding Opportunity Announcement (FOA) encourages the translation of technologies for biomedical or behavioral research from academic and other non-small business research sectors to the marketplace. Small Business Concerns (SBCs) are encouraged to submit Small Business Innovation Research (SBIR) grant applications that propose to further develop, make more robust, and make more user-friendly such technologies in preparation for commercial dissemination. It is expected that this activity will require partnerships and close collaboration between the original developers of these technologies and SBCs, which may be accomplished in any of a number of ways, including the use of multiple principle investigators. -Mechanism of Support. This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications. This FOA runs in parallel with an FOA affiliated with the NIH Blueprint for Neuroscience Research, PA-08-071, Lab to Marketplace Tools for Brain and Behavioral Research. -Funds Available and Anticipated Number of Awards. For this FOA, Budgets up to $350,000 total costs per year and time periods up to 2 years for Phase I may be requested. Budgets up to $600,000 total costs per year and up to 3 years may be requested for Phase II. Phase II competing renewal budgets must be submitted in accordance with participating IC-specific budget limitations described in the SBIR Omnibus Solicitation Program Descriptions and Research Topics. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.
Federal Grant Title: Lab to Marketplace: Tools for Biomedical and Behavioral Research (SBIR [R43/R44])
Federal Agency Name: National Institutes of Health
Grant Categories: Education Food and Nutrition Health
Type of Opportunity: Discretionary
Funding Opportunity Number: PA-08-114
Type of Funding: Grant
CFDA Numbers: 93.172
CFDA Descriptions: Human Genome Research
Current Application Deadline: May 07, 2011
Original Application Deadline: May 07, 2011
Posted Date: Apr 09, 2008
Creation Date: Jan 26, 2009
Archive Date: Jun 07, 2011
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Small businesses
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
Similar Government Grants
Initiative to Maximize Research Education in Genomics: Diversity Action Plan (R25)
The Electronic Medical Records and Genomics (eMERGE): Genomic Risk Assessment and Manageme...
The Electronic Medical Records and Genomics (eMERGE): Genomic Risk Assessment and Manageme...
The Electronic Medical Records and Genomics (eMERGE): Genomic Risk Assessment and Manageme...
International Bioethics Research Training Program (D43 Clinical Trial Optional)
Near-Term Technology Development for Genome Sequencing - SBIR (R43/R44)
Near-Term Technology Development for Genome Sequencing - STTR (R41/R42)
Revolutionary Genome Sequencing Technologies - The $1000 Genome - SBIR (R43/R44)
More Grants from the National Institutes of Health
Ethical Issues in Translational Science Research (R01 Clinical Trial Optional)
A Collaborative Network to Optimize Emergency Care of Older Adults with Alzheimers Disease...
Innovations to Foster Healthy Longevity in Low-Income Settings (R03 Clinical Trial Not All...
HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Instit...
National Dental Practice-Based Research Network Clinical Trial or Observational Study Plan...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2019 FederalGrants.com